| Nombre | YANELI JUAREZ VICUÑA |
|---|---|
| Área | BIOLOGÍA Y QUÍMICA |
| Campo | CIENCIAS MÉDICAS |
| Disciplina | BIOLOGÍA MOLECULAR |
| Especialidad | EXPRESION |
| CVU | 481471 |
| Institución | |
|---|---|
| Dependencia | SIN INFORMACIÓN |
| Entidad | CIUDAD DE MEXICO |
| Nivel | C |
| Vigencia | Inicio: 01/01/2023 |
| Fin: 31/12/2026 |
Publicaciones ORCID
- 2026
- Regulatory Roles of Long Non-Coding RNAs in Methotrexate Pharmacology: Mechanistic and Translational Insights Pharmaceutical Research
- Cross Cultural Validation of Work Productivity and Activity Impairment Questionnaire in Lupus Patients From Latin America International Journal of Rheumatic Diseases
- 2025
- Niveles séricos de metaloproteinasas como biomarcadores predictivos de eventos cardiovasculares adversos en hombres con infarto con elevación del segmento ST Archivos de Cardiología de México
- 2024
- LncRNA MALAT1 in Keratinocyte function: A review of recent advances. Non-coding RNA research
- 2023
- Mononuclear cells from patients with rhupus are influenced by TNF in their production of gp130/sIL-6Rb and APRIL. Lupus science & medicine
- Diagnostic Performance of Serum MicroRNAs for ST-Segment Elevation Myocardial Infarction in the Emergency Department. Biomedicines
- 2022
- lncRNAs dysregulation in monocytes from primary antiphospholipid syndrome patients: a bioinformatic and an experimental proof-of-concept approach. Molecular biology reports
- Interferon-alpha regulates expression of lncRNA MALAT1 and interferon-stimulated genes, as well as chemokine production, in primary Sjögren's syndrome. Clinical and experimental rheumatology
- Elevated Levels of Soluble CD147 are Associated with Hyperinflammation and Disease Severity in COVID-19: A Proof-of-Concept Clinical Study. Archivum immunologiae et therapiae experimentalis
- Antinuclear antibodies detected by Enzyme-Linked Immunosorbent Assay (ELISA) in severe COVID-19: clinical and laboratory associations. European review for medical and pharmacological sciences